Furthermore, we added reagents that could dissociate the binding of hexokinase and VDAC1, including methyl jasmonate and clotrimazole, to cisplatin in the SiHa and CaSki cervical cancer cells to detect their effects on cell viability. The gene discussed is VDAC1; the disease is cervical carcinoma.